Spurring Vaccine Development for the Developing World: A Collaborative Governance Perspective on Product Development Partnerships

References

• Ansell, C., & Gash, A. (2008). Collaborative governance in theory and practice. Journal of Public Administration Research and Theory, 18(4), 543–571. doi:10.1093/jopart/mum032
   Web of Science ®Google Scholar
• Bishai, D. M., Champion, C., Steele, M. E., & Thompson, L. (2011). Product development partnerships hit their stride: Lessons from developing a meningitis vaccine for Africa. Health Affairs, 30(6), 1058–1064. doi:10.1377/hlthaff.2011.0295
   Web of Science ®Google Scholar
• Borrini-Feyerabend, G. (1996). Collaborative management of protected areas: Tailoring the approach to the context. Gland, Switzerland: IUCN-The World Conservation Union.
   Google Scholar
• Boulding, K. E. (1956). General systems theory—The skeleton of science. Management Science, 2(3), 197–208. doi:10.1287/mnsc.2.3.197
   Web of Science ®Google Scholar
• Bozeman, B. (2002). Public-value failure: When efficient markets may not do. Public Administration Review, 62(2), 145–161. doi:10.1111/puar.2002.62.issue-2
   Web of Science ®Google Scholar
• Bozeman, B. (2007). Public values and public interest: Counterbalancing economic individualism. Washington, DC: Georgetown University Press.
   Google Scholar
• Breitstein, J., & Spigelman, M. (2013). The role of product development partnerships in advancing the development of drugs for unmet needs. Clinical Pharmacology and Therapeutics, 93(6), 468–470. doi:10.1038/clpt.2013.53
   PubMed Web of Science ®Google Scholar
• Brown, T. L., Gong, T., & Jing, Y. (2012). Collaborative governance in mainland China and Hong Kong: Introductory essay. International Public Management Journal, 15(4), 393–404.
   Web of Science ®Google Scholar
• Bryce, H. (2006). Nonprofits as social capital and agents in the public policy process: Toward a new paradigm. Nonprofit and Voluntary Sector Quarterly, 35(2), 311–318. doi:10.1177/0899764005283023
   Web of Science ®Google Scholar
• Bryson, J. M., Crosby, B. C., & Stone, M. M. (2006). The design and implementation of cross‐sector collaborations: Propositions from the literature. Public Administration Review, 66(s1), 44–55. doi:10.1111/puar.2006.66.issue-s1
   Web of Science ®Google Scholar
• Buse, K., & Walt, G. (2000). Global public-private partnerships: Part I—A new development in health? Bulletin of the World Health Organization, 78(4), 549–561.
   PubMed Web of Science ®Google Scholar
• Chataway, J., & Smith, J. (2006). The International AIDS Vaccine Initiative (IAVI): Is it getting new science and technology to the world’s neglected majority? World Development, 34, 16–30. doi:10.1016/j.worlddev.2005.07.010
   Web of Science ®Google Scholar
• Chen, B. (2010). Antecedents or processes? Determinants of perceived effectiveness of interorganizational collaborations for public service delivery. International Public Management Journal, 13(4), 381–407. doi:10.1080/10967494.2010.524836
   Web of Science ®Google Scholar
• Cohen, J. P., Sturgeon, G., & Cohen, A. (2014). Measuring progress in neglected disease drug development. Clinical Therapeutics, 36(7), 1037–1042. doi:10.1016/j.clinthera.2014.05.004
   PubMed Web of Science ®Google Scholar
• Coles, L. D., & Cloyd, J. C. (2012). The role of academic institutions in the development of drugs for rare and neglected diseases. Clinical Pharmacology & Therapeutics, 92(2), 193–202. doi:10.1038/clpt.2012.83
   PubMed Web of Science ®Google Scholar
• Connolly, J. (2010). Questions for biotechs: AERAS. Human Vaccines, 6(12), 962–963. doi:10.4161/hv.6.12.14485
   PubMed Web of Science ®Google Scholar
• Craig, M. H., Snow, R. W., & Le Sueur, D. (1999). A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitology Today, 15(3), 105–111. doi:10.1016/S0169-4758(99)01396-4
   PubMedGoogle Scholar
• Dixon, S., McDonald, S., & Roberts, J. (2002). The impact of HIV and AIDS on Africa’s economic development. British Medical Journal, 324(7331), 232–234. doi:10.1136/bmj.324.7331.232
   PubMed Web of Science ®Google Scholar
• Eiss, R., Hanna, K. E., & Mahoney, R. T. (2007). Ensuring global access through effective IP management: Strategies of product-development partnerships. In A. Anatole Krattiger, R. T. Mahoney, L. Nelsen, J. A. Thomson, A. B. Bennett, K. Satyanarayana … S. P. Kowalski (Eds.), Intellectual property in health and agricultural innovation: A handbook of best practices (pp. 63–78). Oxford, UK; Davis, CA: MIHR and PIPRA. Retrieved from http://www.iphandbook.org
   Google Scholar
• Emerson, K., Nabatchi, T., & Balogh, S. (2012). An integrative framework for collaborative governance. Journal of Public Administration Research and Theory, 22(1), 1–29. doi:10.1093/jopart/mur011
   Web of Science ®Google Scholar
• Feeney, M. K., & Bozeman, B. (2007). Public values and public failure: Implications of the 2004–2005 flu vaccine case. Public Integrity, 9(2), 175–190. doi:10.2753/PIN1099-9922090204
   Google Scholar
• Frederickson, H. G. (2012). The public administration theory primer. Boulder, CO: Westview Press.
   Google Scholar
• Freeman, J. (1997). Collaborative governance in the administrative state. UCLA Law Review, 45(1), 1–98.
   Web of Science ®Google Scholar
• Grace, C. (2010). Product development partnerships (PDPs): Lessons from PDPs established to develop new health technologies for neglected diseases. London , UK: Great Britain, Department for International Development, Human Development Resource Centre.
   Google Scholar
• Hotez, P. J., Fenwick, A., Savioli, L., & Molyneux, D. H. (2009). Rescuing the bottom billion through control of neglected tropical diseases. The Lancet, 373(9674), 1570–1575. doi:10.1016/S0140-6736(09)60233-6
   PubMed Web of Science ®Google Scholar
• Hotez, P. J., Molyneux, D. H., Fenwick, A., Kumaresan, J., Sachs, S. E., Sachs, J. D., & Savioli, L. (2007). Control of neglected tropical diseases. New England Journal of Medicine, 357(10), 1018–1027. doi:10.1056/NEJMra064142
   PubMed Web of Science ®Google Scholar
• Hotez, P. J., Molyneux, D. H., Fenwick, A., Ottesen, E., Sachs, S. E., & Sachs, J. D. (2006). Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Medicine, 3(5), e277. doi:10.1371/journal.pmed.0030102
   PubMed Web of Science ®Google Scholar
• Huxham, C. (2000). The challenge of collaborative governance. Public Management, 2(3), 337–357. doi:10.1080/14616670050123260
   Google Scholar
• Jing, Y., & Chen, B. (2012). Is competitive contracting really competitive? Exploring government-nonprofit collaboration in China. International Public Management Journal, 15(4), 405–428.
   Web of Science ®Google Scholar
• Kapucu, N., & Garayev, V. (2011). Collaborative decision-making in emergency and disaster management. International Journal of Public Administration, 34(6), 366–375. doi:10.1080/01900692.2011.561477
   Google Scholar
• Kettler, H., White, K., & Jordan, S. (2003). Valuing industry contributions to public-private partnerships for health product development. Geneva, Switzerland: Initiative on Public-Private Partnerships for Health.
   Google Scholar
• Koppell, J. G. S. (2010). Administration without borders. Public Administration Review, 70(s1), s46–s55. doi:10.1111/puar.2010.70.issue-s1
   Google Scholar
• Kremer, M., & Glennerster, R. (2004). Strong medicine: Creating incentives for pharmaceutical research on neglected diseases. Princeton, NJ: Princeton University Press.
   Google Scholar
• Ledford, H. (2008). HIV vaccine developers battle on, despite high-profile failures. Nature Biotechnology, 26(6), 591–592. doi:10.1038/nbt0608-591
   PubMed Web of Science ®Google Scholar
• Lee, E. W. Y., & Liu, H. K. (2012). Factors influencing network formation among social service nonprofit organizations in Hong Kong and implications for comparative and China studies. International Public Management Journal, 15(4), 454–478.
   Web of Science ®Google Scholar
• Lucas, S. B., Hounnou, A., Peacock, C., Beaumel, A., Djomand, G., N’Gbichi, J., Yeboue, K., et al. (1993). The mortality and pathology of HIV infection in a west African city. Aids, 7(12), 1569–1579. doi:10.1097/00002030-199312000-00005
   PubMed Web of Science ®Google Scholar
• Lucas, S. B., Michael, O., & Wabinga, H. (1991). The pathology of severe morbidity and mortality caused by HIV infection in Africa. Aids, 5, S143–S148.
   PubMed Web of Science ®Google Scholar
• Merz, J. F. (2005). Intellectual property and product development public/private partnerships. Geneva, Switzerland: World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health.
   Google Scholar
• Moran, M., Guzman, J., Chapman, N., Abela-Oversteegen, L., Whittall, C., Howard, R. … Hirst, C. (2014). Neglected disease research & development: Emerging trends. Sydney, Australia: Policy Cures.
   Google Scholar
• Moulton, S., & Eckerd, A. (2012). Preserving the publicness of the nonprofit sector: Resources, roles, and public values. Nonprofit and Voluntary Sector Quarterly, 41(4), 656–685. doi:10.1177/0899764011419517
   Web of Science ®Google Scholar
• Mrazek, M. F., & Mossialos, E. (2003). Stimulating pharmaceutical research and development for neglected diseases. Health Policy, 64(1), 75–88. doi:10.1016/S0168-8510(02)00138-0
   PubMed Web of Science ®Google Scholar
• Nwaka, S., & Ridley, R. G. (2003). Virtual drug discovery and development for neglected diseases through public–private partnerships. Nature Reviews Drug Discovery, 2(11), 919–928. doi:10.1038/nrd1230
   PubMed Web of Science ®Google Scholar
• Nye, J. S., Zelikow, P., & King, D. C. (1997). Why people don’t trust government. Cambridge, Mass: Harvard University Press.
   Google Scholar
• O‘Leary, R., Gerard, C., & Bingham, L. B. (2006). Introduction to the symposium on collaborative public administration. Public Administration Review, 66(s1), 6–9. doi:10.1111/j.1540-6210.2006.00661.x
   Web of Science ®Google Scholar
• Prebble, M. (2015). Public value and limits to collaboration. International Journal of Public Administration, 38(7), 473–485.
   Web of Science ®Google Scholar
• Provan, K. G., & Kenis, P. (2008). Modes of network governance: Structure, management, and effectiveness. Journal of Public Administration Research and Theory, 18(2), 229–252. doi:10.1093/jopart/mum015
   Web of Science ®Google Scholar
• Raviglione, M. C., Snider, D. E., & Kochi, A. (1995). Global epidemiology of tuberculosis: Morbidity and mortality of a worldwide epidemic. Journal of American Medical Association, 273(3), 220–226. doi:10.1001/jama.1995.03520270054031
   PubMed Web of Science ®Google Scholar
• Reich, M. R. (2000). The global drug gap. Science, 287(5460), 1979–1981. doi:10.1126/science.287.5460.1979
   PubMed Web of Science ®Google Scholar
• Reich, M. R. (2002). Public-private partnerships for public health. Cambridge, MA: Harvard Center for Population and Development Studies.
   Google Scholar
• Rhodes, R. A. W. (1996). The new governance: Governing without government. Political Studies, 44(4), 652–667. doi:10.1111/j.1467-9248.1996.tb01747.x
   Web of Science ®Google Scholar
• Skelcher, C. (2000). Changing images of the State: Overloaded, hollowed-out, congested. Public Policy and Administration, 15(3), 3–19. doi:10.1177/095207670001500302
   Google Scholar
• Sy, A., & Copley, A. (2014). Understanding the economic effects of the 2014 Ebola outbreak in West Africa. Washington, DC: Global Economy and Development, The Brookings Institution.
   Google Scholar
• Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R., & Ford, N. (2002). Drug development for neglected diseases: A deficient market and a public-health policy failure. The Lancet, 359(9324), 2188–2194. doi:10.1016/S0140-6736(02)09096-7
   PubMed Web of Science ®Google Scholar
• Veeken, H., & Pécoul, B. (2000). Drugs for “neglected diseases”: A bitter pill. Tropical Medicine & International Health, 5(5), 309–311. doi:10.1046/j.1365-3156.2000.00576.x
   PubMed Web of Science ®Google Scholar
• Wang, F., & Haitao, Y. (2012). A new form of governance or the reunion of the government and business sector? A case analysis of the collaborative natural disaster insurance system in the Zhejiang Province of China. International Public Management Journal, 15(4), 429–453.
   Web of Science ®Google Scholar
• Widdus, R. (2001). Public-private partnerships for health: Their main targets, their diversity, and their future directions. Bulletin of the World Health Organization, 79(8), 713–720.
   PubMed Web of Science ®Google Scholar
• Widdus, R., & White, K. (2004). Combating diseases associated with poverty: Financing strategies for product development and the potential role of public-private partnerships. Geneva, Switzerland: Initiative for Public-Private Partnerships for Health.
   Google Scholar
• World Bank. (1998). The Bank’s relations with NGOs: Issues and directions. Washington, DC: NGO Unit, Social Development.
   Google Scholar
• World Health Organization. (2015). One year into the Ebola epidemic: A deadly, tenacious and unforgiving virus. Geneva, Switzerland: World Health Organization.
   Google Scholar